Moreover, recent studies have shown that NR4A1 induces TNFα-mediated apoptosis sensitivity in human gastric cancer [38] and improves cisplatin resistance in ovarian cancer [39], supporting that NR4A1 plays a crucial role in drug therapy sensitivity in a variety of tumor models. Here, NR4A1 is linked to ovarian cancer.